These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13353714)

  • 1. [Experience in mass vaccination against Q fever. I. Capacity of Q fever vaccine to produce reactivity and immunity].
    ZUBKOVA RI; FEDOROVA NI; KALMYKOV NL
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jul; 27(7):24-7. PubMed ID: 13353714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Result of mass vaccination against Q fever. II. Remote results of vaccination].
    ZUBKOVA RI; FEDOROVA NI; KALMYKOV NL
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Nov; 27(11):18-20. PubMed ID: 13410087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in mass immunization of humans with the M-44 live vaccine against Q-fever. 2. Skin and oral routes of immunization].
    Genig VA
    Vopr Virusol; 1965; 10(6):703-7. PubMed ID: 4225871
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in preparation of vaccine against Q fever].
    KHODUKIN NI; SHTERNGOL'D EIa; SHLEIKHER EI; ZVAGEL'SKAIA VN
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jul; 27(7):22-3. PubMed ID: 13353713
    [No Abstract]   [Full Text] [Related]  

  • 5. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Solution of active specific prevention of Q fever. II. Experiences with vaccination against Q fever in man].
    VASIL'EVA LV; IABLONSKAIA VA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jun; 6():50-4. PubMed ID: 13248125
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick DA; Izzo AA; Esterman A; Feery B; Shapiro RA
    Epidemiol Infect; 1990 Apr; 104(2):275-87. PubMed ID: 2323360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a Q fever vaccination program for high-risk patients in the Netherlands.
    Isken LD; Kraaij-Dirkzwager M; Vermeer-de Bondt PE; Rümke HC; Wijkmans C; Opstelten W; Timen A
    Vaccine; 2013 May; 31(23):2617-22. PubMed ID: 23583810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
    Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
    Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific vaccination against Q fever].
    FEDOROVA NI; TAV'EV BM; RUMIANTSEVA EV
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Aug; 29(8):75-80. PubMed ID: 13605068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Result of double vaccination against Q fever].
    KULAGIN SM; FUKI AD; ZUBKOVA RI; POPOVA LD
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Nov; 29(11):25-9. PubMed ID: 13626096
    [No Abstract]   [Full Text] [Related]  

  • 13. Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013.
    Bond KA; Franklin LJ; Sutton B; Firestone SM
    Vaccine; 2017 Dec; 35(51):7084-7087. PubMed ID: 29132996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine prophylaxis of abattoir-associated Q fever.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick D; Cameron S; Esterman A; Feery B; Collins W
    Lancet; 1984 Dec; 2(8417-8418):1411-4. PubMed ID: 6151039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control strategies for Q fever based on results of pre-vaccination screening in Victoria, 1988 to 2001.
    Greig JE; Patel MS; Clements MS; Taylor NK
    Aust N Z J Public Health; 2005 Feb; 29(1):53-7. PubMed ID: 15782873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Q fever vaccines: present status and application in man.
    Kazár J; Rehácek J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Nov; 267(1):74-8. PubMed ID: 3324573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Components of protective immunity.
    Zhang G; Zhang Y; Samuel JE
    Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination of sheep against Q fever].
    SHIFRIN Ia; ROZHKOV FV; TRUBA IV
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Aug; 29(8):97-101. PubMed ID: 13605074
    [No Abstract]   [Full Text] [Related]  

  • 19. Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine.
    Izzo AA; Marmion BP; Worswick DA
    J Infect Dis; 1988 Apr; 157(4):781-9. PubMed ID: 3346570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the Q fever vaccine: a meta-analysis.
    Gefenaite G; Munster JM; van Houdt R; Hak E
    Vaccine; 2011 Jan; 29(3):395-8. PubMed ID: 21094268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.